Armistice Capital »

A. O. Smith Corporation shares owned by Armistice Capital

Quarter-by-quarter ownership of A. O. Smith Corporation (AOS) shares owned by Armistice Capital from 13F filings

Historical chart of Armistice Capital investment in A. O. Smith Corporation

Tip: Access up to 7 years of quarterly data

All positions including A. O. Smith Corporation held by Armistice Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in A. O. Smith Corporation by Armistice Capital

Quarter filed Position value Share count Share price at filing
2026-06-30 $203k 3.2k 62.72

More positions owned by Armistice Capital

State Str Spdr S&p 500 Etf T Tr Unit Put Option (SPY)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Cytokinetics Com New (CYTK)
Agios Pharmaceuticals (AGIO)
Madrigal Pharmaceuticals (MDGL)
Ptc Therapeutics I (PTCT)
Supernus Pharmaceuticals (SUPN)
Travere Therapeutics (TVTX)
Immunovant (IMVT)
Incyte Corporation (INCY)
Neurocrine Biosciences (NBIX)
UnitedHealth (UNH)
Mineralys Therapeutics (MLYS)
Freshpet (FRPT)
Dyne Therapeutics (DYN)

View all positions for Armistice Capital

Top funds holding A. O. Smith Corporation

FMR
BlackRock
Vanguard Capital Management
Vanguard Portfolio Management
State Street Corporation
Invesco
American Century Companies
Geode Capital Management
Morgan Stanley
Impax Asset Management Group
ProShare Advisors
UBS Group
First Trust Advisors
Dimensional Fund Advisors
Earnest Partners

View all funds holding A. O. Smith Corporation